1-4 of 4
Tetsuhiko Shirasaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)

Bunzo Nakata, Yasushi Mitachi, Akihito Tsuji, Susumu Yamamitsu, Koichi Hirata, Tetsuhiko Shirasaka, Kosei Hirakawa
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (5): 1664–1669.
https://doi.org/10.1158/1078-0432.CCR-03-0045
Published: 10 March 2004
View article titled, Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)
Open the PDF for Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902) in another window
Journal Articles

Low-Dose Cisplatin and 5-Fluorouracil in Combination CanRepress Increased Gene Expression of Cellular Resistance Determinants to Themselves

Masahiko Nishiyama, Wataru Yamamoto, Ji-Seon Park, Ryo Okamoto, Hoken Hanaoka, Hiroshi Takano, Norio Saito, Masaaki Matsukawa, Tetsuhiko Shirasaka, Minoru Kurihara
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2620–2628.
Published: 01 September 1999
View article titled, Low-Dose Cisplatin and 5-Fluorouracil in Combination CanRepress Increased Gene Expression of Cellular Resistance Determinants to Themselves
Open the PDF for Low-Dose Cisplatin and 5-Fluorouracil in Combination CanRepress Increased Gene Expression of Cellular Resistance Determinants to Themselves in another window
Journal Articles

Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug

Koichi Hirata, Noboru Horikoshi, Keisuke Aiba, Minoru Okazaki, Ryuichi Denno, Kazuaki Sasaki, Yasuyuki Nakano, Hikaru Ishizuka, Yasuhide Yamada, Shinji Uno, Tetsuo Taguchi, Tetsuhiko Shirasaka
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2000–2005.
Published: 01 August 1999
View article titled, Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug
Open the PDF for Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug in another window
Journal Articles

Persistent Induction of Apoptosis and Suppression of Mitosis as the Basis for Curative Therapy with S-1, an Oral 5-Fluorouracil Prodrug in a Colorectal Tumor Model

Shousong Cao, Kun Lu, Karoly Tóth, Harry K. Slocum, Tetsuhiko Shirasaka, Youcef M. Rustum
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 267–274.
Published: 01 February 1999
View article titled, Persistent Induction of Apoptosis and Suppression of Mitosis as the Basis for Curative Therapy with S-1, an Oral 5-Fluorouracil Prodrug in a Colorectal Tumor Model
Open the PDF for Persistent Induction of Apoptosis and Suppression of Mitosis as the Basis for Curative Therapy with S-1, an Oral 5-Fluorouracil Prodrug in a Colorectal Tumor Model in another window